NEW YORK (GenomeWeb) – Molecular diagnostics firm Nanosphere reported after the close of the market today record preliminary revenues for the fourth quarter and full-year 2015.

The company said revenue rose 48 percent year over year in Q4 to $6.8 million from $4.6 million in Q4 2014. Nanosphere also reported preliminary full-year 2015 revenues of $21 million, a 47 percent increase over $14.3 million in 2014 and above its 2015 revenue guidance of $18 million to $20 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.